Featured Research

from universities, journals, and other organizations

Study Reveals Cancer Role Of Mutated Gene

Date:
May 25, 1999
Source:
University Of North Carolina School Of Medicine
Summary:
Scientists at the University of North Carolina at Chapel Hill have discovered the molecular role in cancer development of a mutated tumor suppressor gene known as ARF. The new findings help clarify why ARF is the second most frequently mutated gene in human cancers, appearing in 40 percent of malignancies, second only to the mutated tumor suppressor gene, p53.

CHAPEL HILL, N.C. - Scientists at the University of North Carolina at Chapel Hill have discovered the molecular role in cancer development of a mutated tumor suppressor gene known as ARF.

The new findings help clarify why ARF is the second most frequently mutated gene in human cancers, appearing in 40 percent of malignancies, second only to the mutated tumor suppressor gene, p53.

According to a report in the journal Molecular Cell, published May 20, ARF normally prevents cellular transformation by preventing degradation of the p53 protein. It allows p53 to accumulate in the cell's nucleus where it functions to stop tumor cell growth.

"We previously reported our discovery that the ARF protein functions to suppress tumor growth by biochemically binding to another protein called MDM2," says Dr. Yue Xiong, assistant professor of biochemistry and biophysics at the UNC-CH School of Medicine. "Under normal conditions, MDM2 binds with p53 and takes it to the cellular cytoplasm for degradation. ARF will stop this process, accumulating p53 in the nucleus."

In the new study, Xiong and Dr.Yanping Zhang, a postdoctoral researcher in his laboratory at the UNC Lineberger Comprehensive Cancer Center, for the first time have described how a normally-functioning ARF does that. Essentially, it binds with MDM2 and p53 to form a structure called a nuclear body. This structure prevents MDM2 and p53 from leaving the nucleus and entering the cytoplasm, where the proteins would otherwise be degraded, broken down.

"When these proteins all come together, p53 cannot go from the nucleus to the cytoplasm. So ARF blocks p53 nuclear export," Xiong says.

The researchers also focused on what happens when ARF becomes mutated. They demonstrated for the first time how the ability of a mutated ARF to fulfill its tumor-suppressing role is impaired - a demonstration based on three discoveries.

First, Zhang and Xiong discovered that ARF is normally located in the cell's nucleolis, a small rounded mass within the cell's nucleus. Second, they determined the DNA sequence in ARF (located in an area of the gene called Exon 2) that is responsible for "localizing" or getting this protein directly to the nucleolis.

This finding led them to link ARF's Exon 2 with cancer, "because many ARF mutations associated with human cancer are clustered in this area and are predicted to disrupt ARF's normal localization," Xiong explains.

"So we tested whether mutations derived from cancer patients would mislocalize ARF and impair its ability to block p53 export and degradation. The answer is yes," Xiong states. "With ARF mutated and mislocalized, oncogenes go unchecked and cells proliferate abnormally, initiating oncogenesis."


Story Source:

The above story is based on materials provided by University Of North Carolina School Of Medicine. Note: Materials may be edited for content and length.


Cite This Page:

University Of North Carolina School Of Medicine. "Study Reveals Cancer Role Of Mutated Gene." ScienceDaily. ScienceDaily, 25 May 1999. <www.sciencedaily.com/releases/1999/05/990525061736.htm>.
University Of North Carolina School Of Medicine. (1999, May 25). Study Reveals Cancer Role Of Mutated Gene. ScienceDaily. Retrieved July 24, 2014 from www.sciencedaily.com/releases/1999/05/990525061736.htm
University Of North Carolina School Of Medicine. "Study Reveals Cancer Role Of Mutated Gene." ScienceDaily. www.sciencedaily.com/releases/1999/05/990525061736.htm (accessed July 24, 2014).

Share This




More Health & Medicine News

Thursday, July 24, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

New Painkiller Designed To Discourage Abuse: Will It Work?

New Painkiller Designed To Discourage Abuse: Will It Work?

Newsy (July 24, 2014) The FDA approved Targiniq ER on Wednesday, a painkiller designed to keep users from abusing it. Like any new medication, however, it has doubters. Video provided by Newsy
Powered by NewsLook.com
Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Newsy (July 24, 2014) Sheik Umar Khan has treated many of the people infected in the Ebola outbreak, and now he's become one of them. Video provided by Newsy
Powered by NewsLook.com
Condemned Man's US Execution Takes Nearly Two Hours

Condemned Man's US Execution Takes Nearly Two Hours

AFP (July 24, 2014) America's death penalty debate raged Thursday after it took nearly two hours for Arizona to execute a prisoner who lost a Supreme Court battle challenging the experimental lethal drug cocktail. Duration: 00:55 Video provided by AFP
Powered by NewsLook.com
China's Ageing Millions Look Forward to Bleak Future

China's Ageing Millions Look Forward to Bleak Future

AFP (July 24, 2014) China's elderly population is expanding so quickly that children struggle to look after them, pushing them to do something unexpected in Chinese society- move their parents into a nursing home. Duration: 02:07 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins